Cribriform-negative disease had a low metastasis rate unaffected by treatment. After radiation therapy with neoadjuvant ADT group, men with cribriform-positive disease had the same metastasis rate as ...
New research presented at the 2025 International Kidney Cancer Symposium found that patients with localized renal cell ...
A new long-term prediction tool estimates the risk of dying from prostate cancer, offering a more accurate way to interpret ...
Researchers at Case Western Reserve University have developed a treatment for advanced prostate cancer that could eliminate a ...
The Urology Care Foundation and the Prostate Cancer Foundation have created a new educational guide on genetic tests to guide ...
While most prostate cancers grow slowly, some may classify as aggressive prostate cancers based on stage and grade. Prostate cancers mostly consist of adenocarcinomas, which develop within the ...
Pluvicto (lutetium Lu 177 vipivotide tetraxetan) is a medicine that is used to treat prostate cancer in adults. Pluvicto may be used to treat PSMA-positive prostate cancer that has spread to other ...
Orgovyx (relugolix) is a medicine used to treat advanced prostate cancer in adults. Advanced prostate cancer means that the cancer has spread outside of the prostate. Advanced cancers have often come ...
Deciding how to diagnose and treat prostate cancer has long been the subject of controversy and uncertainty. A prime example involves prostate-specific antigen (PSA) testing, a blood test for a ...
Count Hall of Fame center Alonzo Mourning as the latest high-profile individual to reveal that he was diagnosed with prostate cancer. The former Charlotte Hornet and Miami Heat star had Stage 3 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback